Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition
- PMID: 31662318
- DOI: 10.1136/annrheumdis-2019-215763
Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition
Abstract
Objectives: Diverse evidence including clinical, genetic and microbiome studies support a major role of the gut microbiome in the common immune-mediated arthropathy, ankylosing spondylitis (AS). We set out to (1) further define the key microbial characteristics driving disease, and (2) examine the effects of tumour necrosis factor-inhibitor (TNFi) therapy upon the microbiome.
Methods: The stools from a case-control cohort of 250 Han-Chinese subjects underwent shotgun metagenomic sequencing. All subjects were genotyped using the Illumina CoreExome SNP microarray.
Results: Previous reports of gut dysbiosis in AS were reconfirmed and several notable bacterial species and functional categories were differentially abundant. TNFi therapy was correlated with a restoration the perturbed microbiome observed in untreated AS cases to that of healthy controls, including several important bacterial species that have been previously associated with AS and other related diseases. Enrichment of bacterial peptides homologous to HLA-B27-presented epitopes was observed in the stools of patients with AS, suggesting that either HLA-B27 fails to clear these or that they are involved in driving HLA-B27-associated immune reactions. TNFi therapy largely restored the perturbed microbiome observed in untreated AS cases to that of healthy controls, including several important bacterial species that have been previously associated with AS and other related diseases. TNFi therapy of patients with AS was also associated with a reduction of potentially arthritogenic bacterial peptides, relative to untreated patients.
Conclusion: These findings emphasise the key role that the gut microbiome plays in driving the pathogenesis of AS and highlight potential therapeutic and/or preventative targets.
Keywords: Ankylosing Spondylitis; Anti-TNF; Spondyloarthritis.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.Genome Biol. 2017 Jul 27;18(1):142. doi: 10.1186/s13059-017-1271-6. Genome Biol. 2017. PMID: 28750650 Free PMC article.
-
The correlation between intestinal dysbiosis and the development of ankylosing spondylitis.Microb Pathog. 2019 Jul;132:188-192. doi: 10.1016/j.micpath.2019.04.038. Epub 2019 Apr 27. Microb Pathog. 2019. PMID: 31039390 Review.
-
HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome.Arthritis Rheumatol. 2019 Oct;71(10):1642-1650. doi: 10.1002/art.40917. Epub 2019 Aug 12. Arthritis Rheumatol. 2019. PMID: 31038287
-
Gut microbiome and metabolome to discover pathogenic bacteria and probiotics in ankylosing spondylitis.Front Immunol. 2024 Apr 22;15:1369116. doi: 10.3389/fimmu.2024.1369116. eCollection 2024. Front Immunol. 2024. PMID: 38711505 Free PMC article.
-
HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis.Best Pract Res Clin Rheumatol. 2019 Dec;33(6):101499. doi: 10.1016/j.berh.2020.101499. Epub 2020 Apr 9. Best Pract Res Clin Rheumatol. 2019. PMID: 32279929 Review.
Cited by
-
Metabolomic analysis in spondyloarthritis: A systematic review.Front Microbiol. 2022 Sep 2;13:965709. doi: 10.3389/fmicb.2022.965709. eCollection 2022. Front Microbiol. 2022. PMID: 36118235 Free PMC article. Review.
-
Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis.Front Cell Infect Microbiol. 2022 Aug 22;12:973563. doi: 10.3389/fcimb.2022.973563. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36072223 Free PMC article. Review.
-
Gut microbiota and Sjögren's syndrome: a two-sample Mendelian randomization study.Front Immunol. 2023 Jun 13;14:1187906. doi: 10.3389/fimmu.2023.1187906. eCollection 2023. Front Immunol. 2023. PMID: 37383227 Free PMC article.
-
The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.Semin Immunopathol. 2021 Apr;43(2):173-192. doi: 10.1007/s00281-021-00845-0. Epub 2021 Feb 24. Semin Immunopathol. 2021. PMID: 33625549 Review.
-
Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility.Res Sq [Preprint]. 2025 Jul 14:rs.3.rs-6917334. doi: 10.21203/rs.3.rs-6917334/v1. Res Sq. 2025. PMID: 40709250 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials